As of January 22, 2025, Rani Therapeutics (RANI) has a market cap of $87.240 million USD. According to our data, Rani Therapeutics is ranked No.7790 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $87.24 M |
91.16%
|
Dec 31, 2024 | $45.64 M |
-58.73%
|
Dec 29, 2023 | $0.11 B |
-43.73%
|
Dec 30, 2022 | $0.20 B |
-63.91%
|
Dec 31, 2021 | $0.54 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Ironwood Pharmaceuticals
IRWD
|
$0.60 B |
0.000 M
|
USA
|
Entera Bio
ENTX
|
$91.71 M |
-0.000 M
|
Israel
|
Oramed Pharmaceuticals
ORMP
|
$93.12 M |
0.000 M
|
USA
|
Ardelyx
ARDX
|
$1.20 B |
0.000 M
|
USA
|
Seres Therapeutics
MCRB
|
$0.16 B |
-0.000 M
|
USA
|
Synlogic
SYBX
|
$16.73 M |
0.000 M
|
USA
|
Vaxart
VXRT
|
$0.19 B |
-0.000 M
|
USA
|
Amarin Corporation
AMRN
|
$0.22 B |
0.000 M
|
Ireland
|
Market Cap | = | RANI Stock Price | * | RANI Shares Outstanding |
= | $1.49 | * | 33.31 M | |
= | $87.24 M |